Steroid-induced osteoporosis in systemic lupus erythematosus

G. Cunnane; Nancy E Lane

Steroid-induced osteoporosis in systemic lupus erythematosus

Research output: Contribution to journal › Article › peer-review

Abstract

The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.

Original language	English (US)
Pages (from-to)	311-329
Number of pages	19
Journal	Rheumatic Disease Clinics of North America
Volume	26
Issue number	2
State	Published - 2000
Externally published	Yes

ASJC Scopus subject areas

Rheumatology

Fingerprint Dive into the research topics of 'Steroid-induced osteoporosis in systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this

@article{606368e5fce941bfa0d71e46007b3253,

title = "Steroid-induced osteoporosis in systemic lupus erythematosus",

abstract = "The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.",

author = "G. Cunnane and Lane, {Nancy E}",

year = "2000",

language = "English (US)",

volume = "26",

pages = "311--329",

journal = "Rheumatic Disease Clinics of North America",

issn = "0889-857X",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Steroid-induced osteoporosis in systemic lupus erythematosus

AU - Cunnane, G.

AU - Lane, Nancy E

PY - 2000

Y1 - 2000

N2 - The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.

AB - The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.

UR - http://www.scopus.com/inward/record.url?scp=0034086358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034086358&partnerID=8YFLogxK

M3 - Article

C2 - 10768214

AN - SCOPUS:0034086358

VL - 26

SP - 311

EP - 329

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

IS - 2

ER -